EPISODE · Dec 28, 2022 · 4 MIN
FDA D.I.S.C.O. Burst Edition: FDA approves a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant)
from FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) · host U.S. Food and Drug Administration, Center for Drug Evaluation and Research
Listen to a soundcast of the November 18, 2022 FDA approval of a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant).
NOW PLAYING
FDA D.I.S.C.O. Burst Edition: FDA approves a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant)
0:00
4:00
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.)?
This episode is 4 minutes long.
When was this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode published?
This episode was published on December 28, 2022.
What is this episode about?
Listen to a soundcast of the November 18, 2022 FDA approval of a new dosing regimen for asparaginase erwinia chrysanthemi (recombinant).
Can I download this FDA Drug Information Soundcast in Clinical Oncology (D.I.S.C.O.) episode?
Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!